← Browse by Condition
Medical Condition
cancer of the prostate
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 3
NCT07084779
Recruiting
Investigation of Impact of AI on Prostate Cancer Workflow
Enrollment
150 pts
Location
United States
Sponsor
Case Comprehensive Cancer Cent...
NCT07028853 Phase 3
Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Enrollment
1,000 pts
Location
United States, Argen...
Sponsor
Pfizer